CLDX Celldex Therapeutics, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$41.97
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026

CLDX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$41.97
Market Cap
$2.79B
P/E (TTM)
-10.8
EPS (TTM)
$-3.90
Revenue (TTM)
$2M
Div Yield
ROE
-43.8%
Debt/Equity
52W Range
$20 – $45

CLDX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $2M
10-point trend, -77.2%
2016-12-31 2025-12-31
EPS $-3.90
7-point trend, -11.1%
2019-12-31 2025-12-31
Free Cash Flow $-214M
10-point trend, -84.5%
2016-12-31 2025-12-31
Margins -16748.0%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CLDX
Peer Median
P/E (TTM)
5-point trend, +70.4%
-10.8
P/S (TTM)
5-point trend, +201.3%
1807.6
18.3
P/B
5-point trend, -20.3%
5.3
3.3
Price / FCF
5-point trend, +70.9%
-13.1

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CLDX
Peer Median
Operating Margin
5-point trend, -1114.3%
-18599.8%
Net Profit Margin
-16748.0%
-180.4%
ROA
-37.6%
-36.2%
ROE
-43.8%
-43.7%
ROIC
5-point trend, -33.7%
-54.5%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CLDX
Peer Median
Current Ratio
5-point trend, -57.8%
10.5
9.7
Quick Ratio
5-point trend, -58.8%
10.2

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CLDX
Peer Median
Revenue YoY
5-point trend, -66.8%
-78.0%
Revenue CAGR 3Y
5-point trend, -66.8%
-13.1%
Revenue CAGR 5Y
5-point trend, -66.8%
-26.9%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CLDX
Peer Median
EPS (Diluted)
5-point trend, -137.8%
$-3.90

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CLDX
Peer Median

CLDX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 22 analysts
  • Strong Buy 7 31.8%
  • Buy 13 59.1%
  • Hold 2 9.1%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

15 analysts · 2026-08-14
Median target $56.00 +33.4%
Mean target $58.07 +38.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.03%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.94 $-1.08 0.14%
March 31, 2026 $-1.18 $-1.16 -0.02%
Dec. 31, 2025 $-1.22 $-1.03 -0.19%
Sept. 30, 2025 $-1.01 $-0.92 -0.09%
June 30, 2025 $-0.85 $-0.87 0.02%
March 31, 2025 $-0.81 $-0.77 -0.04%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CLDX $1.81B -7.0 -78.0% -16748.0% -43.8%
GRAL $3.45B -7.7 17.2% -277.5% -16.7%
IOVA $1.12B -2.5 60.6% -148.4% -56.0%
ARQT $3.58B -223.4 91.3% -4.3% -9.8%
IMNM $2.43B -8.8 -23.2% -3060.0% -47.0%
IRON $3.01B -13.2 -31.3%
BEAM $2.82B -34.2 120.0% -57.2% -7.0%
NRIX $1.80B -5.8 53.9% -314.9% -53.6%
SLS $577M -15.1 -55.4%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, -56.9% $2M $7M $7M $2M $5M $7M $4M $10M $13M $7M $5M $4M
Cost of Revenue 10-point trend, -87.5% $200.0K $200.0K $300.0K $100.0K $100.0K $200.0K $100.0K $700.0K $700.0K $2M · ·
R&D Expense 12-point trend, +134.8% $245M $164M $118M $82M $53M $43M $43M $66M $96M $103M $100M $104M
SG&A Expense 12-point trend, +112.6% $44M $39M $31M $27M $20M $14M $15M $19M $25M $36M $34M $21M
Operating Expenses 12-point trend, +129.3% $289M $202M $161M $118M $76M $71M $59M $166M $134M $140M $135M $126M
Operating Income 12-point trend, -134.7% $-287M $-195M $-155M $-115M $-71M $-63M $-55M $-156M $-122M $-133M $-130M $-122M
Pretax Income 11-point trend, -103.4% $-259M $-158M $-141M $-112M $-71M $-61M $-51M $-152M $-117M $-129M $-127M ·
Income Tax 7-point trend, +100.0% $0 $0 $0 · $-227.0K $-1M · $-765.0K $-24M · · ·
Net Income 3-point trend, -83.0% $-259M $-158M $-141M · · · · · · · · ·
EPS (Basic) 7-point trend, -11.1% $-3.90 $-2.45 $-2.92 $-2.40 $-1.64 $-2.02 $-3.51 · · · · ·
EPS (Diluted) 7-point trend, -11.1% $-3.90 $-2.45 $-2.92 $-2.40 $-1.64 $-2.02 $-3.51 · · · · ·
Shares (Basic) 7-point trend, +457761.7% 66,422,000 64,395,000 48,449,000 46,888 42,870 29,640 14,507 · · · · ·
Shares (Diluted) 7-point trend, +457761.7% 66,422,000 64,395,000 48,449,000 46,888 42,870 29,640 14,507 · · · · ·
EBITDA 12-point trend, -136.6% $-284M $-192M $-152M $-112M $-68M $-59M $-50M $-153M $-117M $-130M $-127M $-120M
Balance Sheet 24
Annual Balance Sheet data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +3.0% $29M $28M $35M $29M $39M $44M $11M $24M $40M $42M $72M $28M
Short-term Investments 8-point trend, +602.5% $490M $697M $389M $276M $369M $151M $53M $70M · · · ·
Prepaid Expense 12-point trend, +300.5% $14M $21M $5M $12M $2M $2M $1M $2M $3M $4M $4M $4M
Current Assets 12-point trend, +160.8% $535M $747M $432M $318M $411M $198M $67M $99M $145M $196M $295M $205M
PP&E (Net) 12-point trend, -49.4% $5M $4M $4M $4M $4M $4M $4M $6M $10M $13M $11M $11M
PP&E (Gross) 12-point trend, +18.1% $29M $28M $26M $25M $25M $25M $32M $32M $34M $33M $29M $25M
Accum. Depreciation 12-point trend, +68.1% $24M $23M $22M $22M $21M $21M $28M $26M $24M $20M $17M $14M
Goodwill 4-point trend, +914.8% · · · · · · · · $91M $91M $9M $9M
Intangibles 12-point trend, +24.7% $27M $27M $27M $27M $27M $31M $49M $49M $68M $81M $21M $22M
Other Non-current Assets 12-point trend, +675.7% $13M $10M $107.0K $104.0K $104.0K $41.0K $41.0K $2M $2M $2M $1M $2M
Total Assets 12-point trend, +135.1% $583M $792M $466M $353M $445M $236M $123M $156M $316M $383M $338M $248M
Accounts Payable 12-point trend, -54.7% $1M $3M $3M $3M $1M $1M $1M $1M $2M $2M $2M $3M
Accrued Liabilities 12-point trend, +143.7% $47M $34M $22M $13M $12M $8M $6M $7M $19M $29M $24M $19M
Current Liabilities 12-point trend, +108.2% $51M $40M $31M $19M $17M $14M $12M $13M $28M $35M $30M $24M
Capital Leases 7-point trend, -54.2% $784.0K $2M $928.0K $3M $1M $2M $2M · · · · ·
Deferred Tax Flat — no change across 2 periods · · · · · · · · · · $5M $5M
Other Non-current Liabilities 12-point trend, -65.9% $4M $3M $4M $5M $7M $10M $16M $19M $52M $83M $17M $12M
Total Liabilities 12-point trend, +53.5% $56M $45M $36M $27M $25M $26M $29M $32M $79M $118M $47M $36M
Common Stock 12-point trend, -25.6% $67.0K $66.0K $56.0K $47.0K $47.0K $40.0K $17.0K $12.0K $9.0K $121.0K $99.0K $90.0K
Retained Earnings 12-point trend, -291.1% $-1.81B $-1.56B $-1.40B $-1.26B $-1.14B $-1.07B $-1.01B $-962M $-813M $-719M $-591M $-464M
AOCI 12-point trend, +40.0% $4M $3M $3M $1M $2M $3M $3M $3M $3M $3M $2M $3M
Stockholders' Equity 12-point trend, +149.1% $527M $747M $429M $326M $419M $209M $94M $124M $236M $265M $290M $212M
Liabilities + Equity 12-point trend, +135.1% $583M $792M $466M $353M $445M $236M $123M $156M $316M $383M $338M $248M
Shares Outstanding 12-point trend, -25.7% 66,549,442 66,374,549 55,883,377 47,200,695 46,730,198 39,603,771 16,972,077 11,957,635 9,234,693 120,516,654 98,685,595 89,592,779
Cash Flow 13
Annual Cash Flow data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +41.5% $3M $3M $3M $3M $3M $4M $5M $4M $4M $3M $3M $2M
Stock-based Comp 12-point trend, +428.6% $36M $34M $24M $16M $9M $4M $5M $8M $12M $15M $13M $7M
Amort. of Intangibles 7-point trend, -100.0% · · · · · $0 $0 $224.0K $896.0K $997.0K $1M $1M
Other Non-cash $8M · · · · · · · · · · ·
Operating Cash Flow 12-point trend, -107.8% $-211M $-158M $-107M $-104M $-61M $-40M $-46M $-75M $-100M $-113M $-99M $-102M
CapEx 12-point trend, +40.7% $3M $2M $2M $2M $1M $2M $731.0K $813.0K $2M $3M $5M $2M
Investing Cash Flow 11-point trend, +516.6% $209M $-290M $-106M $90M $-216M $-98M $17M $30M $46M $69M $-50M ·
Stock Issued 9-point trend, +128.9% · $432M $216M · $270M $171M $16M $29M $51M $14M $189M ·
Net Stock Activity 9-point trend, +128.9% · $432M $216M · $270M $171M $16M $29M $51M $14M $189M ·
Financing Cash Flow 11-point trend, -98.8% $2M $441M $218M $4M $272M $171M $16M $29M $51M $14M $193M ·
Net Change in Cash 12-point trend, +100.4% $515.0K $-6M $5M $-10M $-5M $33M $-13M $-16M $-2M $-30M $44M $-141M
Taxes Paid Flat — no change across 3 periods $0 $0 $0 · · · · · · · · ·
Free Cash Flow 12-point trend, -106.5% $-214M $-160M $-109M $-106M $-62M $-42M $-47M $-76M $-102M $-116M $-104M $-103M
Profitability 7
Annual Profitability data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Operating Margin 11-point trend, -444.8% -18599.8% -2778.9% -2245.3% -4889.0% -1531.8% -854.1% -1540.2% · -953.7% -1958.7% -2363.9% -3414.1%
Net Margin -16748.0% · · · · · · · · · · ·
Pretax Margin 8-point trend, -1719.2% -16748.0% -2248.8% -2054.8% -4765.6% -1520.9% -821.6% -1424.0% · -920.6% · · ·
EBITDA Margin 11-point trend, -449.1% -18381.0% -2733.6% -2201.6% -4766.1% -1465.8% -801.1% -1404.2% · -919.0% -1913.1% -2309.2% -3347.5%
ROA -37.6% · · · · · · · · · · ·
ROE -43.8% · · · · · · · · · · ·
ROIC 5-point trend, -33.7% -54.5% · · · -16.9% -29.7% · -125.5% -40.8% · · ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +25.3% 10.5 18.9 13.9 17.1 24.9 13.9 5.7 7.9 5.2 5.6 9.8 8.4
Quick Ratio 12-point trend, +788.9% 10.2 18.4 13.6 16.4 24.7 13.7 5.5 1.9 1.5 1.2 2.4 1.1
Efficiency 1
Annual Efficiency data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -81.8% 0.0 0.0 0.0 0.0 0.0 0.0 0.0 · 0.0 0.0 0.0 0.0
Per Share 5
Annual Per Share data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +235.3% $7.92 $11.25 $7.68 $6.91 $8.98 $5.29 $5.54 $10.38 $1.71 $2.20 $2.94 $2.36
Revenue / Share 5-point trend, -100.0% $0.02 $109.01 $142.07 $50.27 $108.49 · · · · · · ·
Cash Flow / Share 5-point trend, +99.8% $-3.18 $-2450.16 $-2214.51 $-2212.34 $-1420.78 · · · · · · ·
Cash / Share 12-point trend, +38.7% $0.43 $0.43 $0.62 $0.62 $0.84 $1.11 $0.66 $2.03 $0.29 $0.35 $0.73 $0.31
EPS (TTM) 7-point trend, -11.1% $-3.90 $-2.45 $-2.92 $-2.40 $-1.64 $-2.02 $-3.51 · · · · ·
Growth Rates 3
Annual Growth Rates data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -109.1% -78.0% 2.0% 192.0% -49.3% -37.3% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -433.7% -13.1% 14.7% -2.5% · · · · · · · · ·
Revenue CAGR 5Y -26.9% · · · · · · · · · · ·
Valuation (TTM) 10
Annual Valuation (TTM) data for CLDX
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, -56.9% $2M $7M $7M $2M $5M $7M $4M $10M $13M $7M $5M $4M
Net Income TTM 3-point trend, -83.0% $-259M $-158M $-141M · · · · · · · · ·
Market Cap 12-point trend, -92.6% $1.81B $1.68B $2.22B $2.10B $1.81B $694M $38M $36M $5.90B $6.40B $23.21B $24.53B
P/E 7-point trend, -996.2% -7.0 -10.3 -13.6 -18.6 -23.6 -8.7 -0.6 · · · · ·
P/S 12-point trend, -82.9% 1169.9 238.9 322.0 892.5 388.2 93.5 10.6 3.8 463.1 943.0 4235.6 6839.4
P/B 12-point trend, -97.0% 3.4 2.2 5.2 6.4 4.3 3.3 0.4 0.3 25.0 24.1 80.0 115.9
P / Tangible Book 6-point trend, -6.9% 3.6 2.3 5.5 7.0 4.6 3.9 · · · · · ·
P / Cash Flow 12-point trend, +96.5% -8.6 -10.6 -20.7 -20.3 -29.6 -17.2 -0.8 -0.5 -59.1 -56.6 -234.7 -241.5
P / FCF 12-point trend, +96.4% -8.5 -10.5 -20.3 -19.9 -29.0 -16.5 -0.8 -0.5 -58.0 -55.3 -223.7 -237.0
Earnings Yield 7-point trend, +90.9% -14.4% -9.7% -7.4% -5.4% -4.2% -11.5% -157.4% · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $2M$7M$7M$2M$5M
Operating Margin % -18599.8%-2778.9%-2245.3%-4889.0%-1531.8%
Net Income $-259M$-158M$-141M
Diluted EPS $-3.90$-2.45$-2.92$-2.40$-1.64
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 10.518.913.917.124.9
Quick Ratio 10.218.413.616.424.7
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-214M$-160M$-109M$-106M$-62M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 277 filers · $2.6B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
62 (+2 vs prior Q) 20 (+7 vs prior Q) 99 (+31 vs prior Q) 56 (+1 vs prior Q) +15.1M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
WELLINGTON MANAGEMENT GROUP LLP $312,415,309 8,396,004 12.07% Shares
Kynam Capital Management, LP $198,065,407 5,322,908 7.65% Shares
STATE STREET CORP $145,134,889 3,900,427 5.61% Shares
VANGUARD CAPITAL MANAGEMENT LLC $128,926,362 3,464,831 4.98% Shares
Deep Track Capital, LP $109,365,809 2,939,151 4.22% Shares
VANGUARD GROUP INC $95,540,813 3,517,703 3.69% Shares
FMR LLC $87,111,215 2,341,070 3.36% Shares
Logos Global Management LP $78,141,000 2,100,000 3.02% Shares
Eversept Partners, LP $66,454,865 1,785,941 2.57% Shares
GEODE CAPITAL MANAGEMENT, LLC $64,373,504 1,729,584 2.49% Shares
Commodore Capital LP $50,233,500 1,350,000 1.94% Shares
Bellevue Group AG $44,652,000 1,200,000 1.72% Shares
BAKER BROS. ADVISORS LP $44,004,955 1,182,611 1.70% Shares
MILLENNIUM MANAGEMENT LLC $43,564,984 1,170,787 1.68% Shares
AMERICAN CENTURY COMPANIES INC $38,787,594 1,042,395 1.50% Shares
EVENTIDE ASSET MANAGEMENT, LLC $38,586,770 1,037,000 1.49% Shares
NOVO HOLDINGS A/S $38,140,250 1,025,000 1.47% Shares
DIMENSIONAL FUND ADVISORS LP $37,326,505 1,003,131 1.44% Shares
Elmind Capital, LP $36,837,900 990,000 1.42% Shares
Driehaus Capital Management LLC $36,817,137 989,442 1.42% Shares
Fisher Asset Management, LLC $36,677,040 985,677 1.42% Shares
Pictet Asset Management Holding SA $34,136,752 917,408 1.32% Shares
Foresite Capital Management VI LLC $32,734,121 879,713 1.26% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $32,132,175 863,536 1.24% Shares
GOLDMAN SACHS GROUP INC $31,451,827 845,252 1.21% Shares
Assenagon Asset Management S.A. $29,347,378 788,696 1.13% Shares
Woodline Partners LP $26,077,884 700,830 1.01% Shares
Affinity Asset Advisors, LLC $26,047,000 700,000 1.01% Shares
Rock Springs Capital Management LP $26,015,223 699,146 1.00% Shares
TWO SIGMA INVESTMENTS, LP $24,604,554 661,235 0.95% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $24,408,048 655,954 0.94% Shares
ALGERT GLOBAL LLC $24,105,978 647,836 0.93% Shares
ADAR1 Capital Management, LLC $23,053,158 619,542 0.89% Shares
PANAGORA ASSET MANAGEMENT INC $21,304,139 572,538 0.82% Shares
VANGUARD FIDUCIARY TRUST CO $20,576,125 552,973 0.79% Shares
5AM Venture Management, LLC $18,503,417 497,270 0.71% Shares
FEDERATED HERMES, INC. $18,340,549 492,893 0.71% Shares
Candriam S.C.A. $17,885,437 481,125 0.69% Shares
Ikarian Capital, LLC $17,804,985 478,500 0.69% Shares
BRAIDWELL LP $16,247,598 436,646 0.63% Shares
Redmile Group, LLC $16,146,200 433,921 0.62% Shares
CITIGROUP INC $14,891,144 400,192 0.58% Shares
Palo Alto Investors LP $14,878,642 399,856 0.57% Shares
TSP Capital Management Group, LLC $13,809,638 371,127 0.53% Shares
PFM Health Sciences, LP $12,753,765 342,751 0.49% Shares
KENNEDY CAPITAL MANAGEMENT LLC $12,738,025 342,328 0.49% Shares
SEGALL BRYANT & HAMILL, LLC $12,513,388 336,291 0.48% Shares
Tetragon Partners GP Ltd $10,807,310 290,441 0.42% Shares
SUPERSTRING CAPITAL MANAGEMENT LP $10,700,963 287,583 0.41% Shares
GordonMD Global Investments LP $10,408,381 279,720 0.40% Shares
BANK OF AMERICA CORP /DE/ $9,518,951 255,817 0.37% Shares
SummitTX Capital, L.P. $9,487,024 254,959 0.37% Shares
SPHERA FUNDS MANAGEMENT LTD. $8,962,698 240,868 0.35% Shares
Rosalind Advisors, Inc. $7,442,000 200,000 0.29% Shares
Universal- Beteiligungs- und Servicegesellschaft mbH $7,285,273 195,788 0.28% Shares
Corient Private Wealth LP $6,925,155 186,110 0.27% Shares
Trexquant Investment LP $6,866,138 184,524 0.27% Shares
Mirador Capital Partners LP $6,737,019 181,054 0.26% Shares
STEMPOINT CAPITAL LP $6,638,711 178,412 0.26% Shares
BlackRock, Inc. $6,469,963 173,877 0.25% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $6,422,446 172,600 0.25% Call option
Cinctive Capital Management LP $5,419,153 145,637 0.21% Shares
BOOTHBAY FUND MANAGEMENT, LLC $5,211,781 140,064 0.20% Shares
FIRST TRUST ADVISORS LP $5,160,357 138,682 0.20% Shares
Swiss National Bank $5,023,350 135,000 0.19% Shares
MONTANOVA CAPITAL, LLC $4,513,461 121,297 0.17% Shares
Connor, Clark & Lunn Investment Management Ltd. $4,481,126 120,428 0.17% Shares
Point72 Asset Management, L.P. $4,361,645 117,217 0.17% Shares
Ikarian Capital, LLC $4,241,940 114,000 0.16% Put option
RHUMBLINE ADVISERS $3,905,662 104,963 0.15% Shares
Propel Bio Management, LLC $3,858,491 103,695 0.15% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3,754,489 100,900 0.15% Put option
Integral Health Asset Management, LLC $3,721,000 100,000 0.14% Shares
DEUTSCHE BANK AG\ $3,601,705 96,794 0.14% Shares
Odyssean, LLC $3,537,517 95,069 0.14% Shares
Caption Management, LLC $3,348,900 90,000 0.13% Put option
MANUFACTURERS LIFE INSURANCE COMPANY, THE $3,324,267 89,338 0.13% Shares
HighVista Strategies LLC $3,235,930 86,964 0.12% Shares
DIADEMA PARTNERS LP $3,200,060 86,000 0.12% Put option
AXA Investment Managers S.A. $3,138,704 121,326 0.12% Shares
Bank of New York Mellon Corp $3,020,782 81,182 0.12% Shares
PDT Partners, LLC $3,010,252 80,899 0.12% Shares
TD Asset Management Inc $2,951,720 79,326 0.11% Shares
ALPS ADVISORS INC $2,945,730 79,165 0.11% Shares
ALLIANCEBERNSTEIN L.P. $2,811,661 88,640 0.11% Shares
XTX Topco Ltd $2,795,773 75,135 0.11% Shares
Seven Fleet Capital Management LP $2,610,802 70,164 0.10% Shares
Birchview Capital, LP $2,600,979 69,900 0.10% Shares
Quantinno Capital Management LP $2,569,276 69,048 0.10% Shares
DAFNA Capital Management LLC $2,549,555 68,518 0.10% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $2,525,864 79,630 0.10% Shares
Man Group plc $2,362,984 63,504 0.09% Shares
Rafferty Asset Management, LLC $2,089,602 56,157 0.08% Shares
Caption Management, LLC $2,072,597 55,700 0.08% Shares
Simplify Asset Management Inc. $1,977,116 53,134 0.08% Shares
DIADEMA PARTNERS LP $1,893,989 50,900 0.07% Call option
Burkehill Global Management, LP $1,860,500 50,000 0.07% Shares
SEVEN GRAND MANAGERS, LLC $1,860,500 50,000 0.07% Shares
VANGUARD ASSET MANAGEMENT, Ltd $1,850,491 49,731 0.07% Shares
MetLife Investment Management, LLC $1,694,060 45,527 0.07% Shares

Company insiders 49 insiders · 19 officers · 23 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Anthony S Marucci PRESIDENT & CEO June 25, 2026 A 27,231 0 0 $0
Una S Ryan President & CEO March 7, 2008 A 899,213 0 0 $0
Samuel Bates Martin SVP AND CFO June 25, 2026 A 24,378 0 0 $0
Avery W Catlin Sr. VP & CFO Sept. 2, 2016 M 83,586 0 0 $0
Teri L Lawver SVP & Chief Commercial Officer June 25, 2026 A 0 0 $0
Freddy A. Jimenez SVP & GENERAL COUNSEL June 25, 2026 A 430 0 0 $0
Margo Heath-Chiozzi SVP OF REGULATORY AFFAIRS June 25, 2026 A 11,247 0 0 $0
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. June 25, 2026 A 408 0 0 $0
Elizabeth Crowley SR. VP & CPDO June 25, 2026 A 4,726 0 0 $0
Diane C. Young SVP, CHIEF MEDICAL OFFICER June 25, 2026 A 2,115 0 0 $0
Tibor Keler EXECUTIVE VP & CSO June 25, 2026 A 7,357 0 0 $0
Ronald Pepin SR. VP & CBO June 25, 2026 A 20,097 0 0 $0
Richard M. Wright Sr. VP & CCO June 17, 2021 A 208 0 0 $0
Theresa Lavallee SVP, Reg.& Precision Medicine Dec. 14, 2016 A 0 0 $0
Ronald C Newbold Sr. VP, Business Dev. Jan. 6, 2009 A 5,868 0 0 $0
Henry C Marsh JR V.P. Research March 7, 2008 M 0 0 $0
Ronald W Ellis Sr VP R&D Jan. 5, 2007 A 0 0 $0
Michael E Furlong Sr. Dir. Bus. Development July 1, 2005 L 1,500 0 0 $0
Alistair Wheeler V.P. Medical Affairs Jan. 2, 2004 A 0 0 $0
Denice Torres Director June 25, 2026 A 0 0 $0
Rita Jain Director June 25, 2026 A 0 0 $0
Garry Arthur Neil Director June 25, 2026 A 0 0 $0
Cheryl Cohen Director June 25, 2026 A 0 0 $0
Keith L Brownlie Director June 25, 2026 A 10,000 0 0 $0
Herbert J Conrad Director June 25, 2026 A 38,500 0 0 $0
James J Marino Director June 25, 2026 A 12,704 0 0 $0
Harry Penner JR Director June 25, 2026 A 41,916 0 0 $0
Karen Shoos Lipton Director June 17, 2021 A 41,833 0 0 $0
Gerald Mcmahon PhD Director Dec. 3, 2018 F 180,697 0 0 $0
Larry Ellberger Director June 13, 2018 A 73,500 0 0 $0
Richard Van Den Broek Director June 8, 2016 A 233,500 0 0 $0
Timothy M Shannon Director June 4, 2014 A 83,212 0 0 $0
Rajesh R Parekh Director Sept. 22, 2010 A 2,000 0 0 $0
Charles R Schaller Director Sept. 9, 2010 P 5,000 0 0 $0
Alf A Lindberg Director May 24, 2007 A 0 0 $0
Francis R Cano Director May 24, 2007 A 0 0 $0
Peter A Sears Director May 24, 2007 A 72,739 0 0 $0
Barrie J Ward Director May 25, 2006 A 367,915 0 0 $0
PDI INC Director May 26, 2005 A 0 0 $0
Frederick W Kyle Director May 13, 2004 C 7,000 0 0 $0
MEDAREX INC 10% owner June 24, 2009 S 2,960,848 0 0 $0
Lorantis Holdings LTD 10% owner April 7, 2008 J 0 0 0 $0
Thomas Andrew Davis June 15, 2017 A 1,011 0 0 $0
George Elston June 8, 2016 A 28,500 0 0 $0
Taha Keilani March 7, 2008 A 2,000 0 0 $0
Paula R Freeman March 7, 2008 M 2,955 0 0 $0
Michael Timothy Cooke Jan. 5, 2007 A 0 0 $0
Mary Nicholson Jan. 3, 2005 A 500 0 0 $0
Anthony Helstosky Jan. 6, 2004 C 6,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Medarex, Inc. I.R.S. Employer Identification Number ×3 filings June 26, 2009 Initial filing SEC
Lorantis Holdings Limited ×2 filings May 12, 2008 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 50 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
SBIO · ALPS ETF Trust 1.33% 68,615 NS May 31, 2026 N-PORT
BBC · ETFis Series Trust I 0.88% 10,032 NS April 30, 2026 N-PORT
LABU · Direxion Shares ETF Trust 0.44% 70,017 NS April 30, 2026 N-PORT
MMSC · First Trust Exchange-Traded Fund VI… 0.23% 3,856 NS May 31, 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0.23% 73,629 NS April 30, 2026 N-PORT
IWO · iShares Trust 0.16% 576,359 SH Aug. 8, 2026 Daily
NUSC · Nushares ETF Trust 0.16% 62,064 NS April 30, 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0.14% 67,853 SH Aug. 8, 2026 Daily
FFSM · FIDELITY COVINGTON TRUST 0.13% 51,835 NS April 30, 2026 N-PORT
FYX · First Trust Exchange-Traded AlphaDE… 0.12% 43,658 NS April 30, 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0.12% 8,106 SH Aug. 8, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.11% 24,795 NS April 30, 2026 N-PORT
IWM · iShares Trust 0.10% 1,997,393 SH Aug. 8, 2026 Daily
SMMV · iShares Trust 0.09% 6,577 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.09% 449,534 SH Aug. 8, 2026 Daily
ISCV · iShares Trust 0.08% 14,142 SH Aug. 8, 2026 Daily
RSSL · Global X Funds 0.08% 32,806 NS April 30, 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.07% 51,058 SH Aug. 8, 2026 Daily
ESML · iShares Trust 0.06% 44,111 SH Aug. 8, 2026 Daily
ITWO · ProShares Trust 0.06% 3,561 NS May 31, 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.05% 368,761 NS May 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.05% 204,021 NS April 30, 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0.05% 6,865 NS April 30, 2026 N-PORT
ISCB · iShares Trust 0.04% 2,846 SH Aug. 8, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.04% 12,901 SH Aug. 8, 2026 Daily
VHT · VANGUARD WORLD FUND 0.04% 201,834 SH Aug. 8, 2026 Daily
IWN · iShares Trust 0.04% 137,013 SH Aug. 8, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.04% 30,973 NS April 30, 2026 N-PORT
UWM · ProShares Trust 0.04% 2,786 NS May 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.03% 897,276 SH Aug. 8, 2026 Daily
WSML · iShares Trust 0.03% 4,615 SH Aug. 8, 2026 Daily
URTY · ProShares Trust 0.03% 2,818 NS May 31, 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0.02% 6,539 NS May 31, 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.01% 2,668 NS May 31, 2026 N-PORT
HDG · ProShares Trust 0.01% 71 NS May 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.01% 7,780 NS April 30, 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0.01% 26,307 NS May 31, 2026 N-PORT
TILT · FlexShares Trust 0.01% 4,620 NS April 30, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 753 NS April 30, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.01% 79,390 NS April 30, 2026 N-PORT
ITOT · iShares Trust 0.01% 117,267 SH Aug. 8, 2026 Daily
IWV · iShares Trust 0.00% 22,367 SH Aug. 8, 2026 Daily
DFAU · Dimensional ETF Trust 0.00% 15,559 NS April 30, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.00% 2,758 NS April 30, 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0.00% 45,244 NS May 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 14,544 NS April 30, 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0.00% 500 NS May 31, 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0.00% 636 NS May 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 2,488,906 SH Aug. 8, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 6,489 SH Aug. 8, 2026 Daily